Healthy clinical trials
Showing 101–150 of 432 active trials. Describe your situation to see which ones you may be eligible for.
- A Study of Invasive Hemodynamic for MACHD Registry
- The SKyRoCKeT Study
- Hyperpolarized 129Xe MRI Lung Health Cohort
- Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments, Using Multiomics
- Observational Study of Exposure to Environmental Toxicants Among Firefighters
- Normal Donor Blood Draws for Platelet Studies and Biomarker Evaluation (ND-PLT)
- Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies
- Selective PET Imaging of Astrocytes and Microglia in Alzheimer's Disease
- Study of Healthy Cohort for Early Detection of Cancer
- Natural History Study of CADASIL
- Bioenergetic Phenotypes and Cardiometabolic Health
- High-resolution Phosphocreatine and Creatine Mapping of Human Muscle and Brain
- Precision Genomics Medicine Biobank
- Imaging Oxidative Metabolism and Neurotransmitter Synthesis in the Human Brain
- The Gut and Skin Microbiome in Vitiligo Disease Progression
- Taste Bud-Derived Stem Cells in Humans
- Influence of Brain Oscillation-Dependent TMS on Motor Function
- Glowing and Expecting Follow Up
- Development and Validation of Multi-nuclear Magnetic Resonance Imaging and Spectroscopy for Whole Body Human Applications
- Gastric Emptying in Neonates and Infants After Formula Feeding
- Characterization Imaging Instruments in Alcoholics and Non-Alcoholics
- Thinking and Memory Problems in People With HIV
- The Healthy Elderly Longevity Cohort
- Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- Evaluation and Optimization of Ultrasound and/or MRI Hardware and Software
- Data Gathering for A10900
- Does a Periaqueductal Gray-vagus Nerve Interface Malfunction Explain the Nat hx With Its Numerous Co-morbidities?
- Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)
- Growth Hormone Resistance of Beta-cells A
- A Study of Neurodegeneration and Neuronal Fluctuations in Lewy Body Disease and Alzheimer's Disease
- A Repository to Study Host-Microbiome Interactions in Health and Disease
- Breathing & Blood Pressure
- Study of Disrupted Sleep in Somali Americans
- Fully Automated High-Throughput Quantitative MRI of the Liver
- Natural History of the Human Biological Response to Environmental Exposure and Injury
- In Vivo Metabolic Profiling of CLL (Chronic Lymphocytic Leukemia)
- PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Skin Microbial Ecology in Atopic Dermatitis
- SV2 PET Imaging With [11C]APP311
- Study of Endocrine-Related Conditions and Physiology
- NIRS Monitoring in Premature Infants
- International (Pediatric) Peritoneal Biobank
- Psychophysical Studies of Cancer Therapy Pain
- Direct to Patient Minimal Risk Biospecimen and Data Collection Research
- Investigational Use of Neuromuscular Ultrasound
- Characterization of the Microbiome in Cutaneous T Cell Lymphoma
- Collection and Distribution of Biospecimens for Novel Research Uses
- Genesis Electrical Impedance Tomography (EIT): A Preliminary Study
- Intraoperative OCT Guidance of Intraocular Surgery II
- New Orleans Pulmonary Hypertension Biobank
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.